LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Animal-Free Insulin and Transferrin Growth Supplement Now Available

By LabMedica International staff writers
Posted on 21 Jun 2010
Investigators working with serum-free culture media are now able to obtain an animal-free media supplement that provides recombinant insulin and transferrin.

ITSE Animal-Free, manufactured by InVitria (Fort Collins, CO, USA), is a recombinant, animal-free media supplement used to improve cell performance. ITSE stands for insulin, transferrin, selenium, and ethanolamine, which are typically required for optimal cell growth in serum-free media.

Ethanolamine is a phospholipid precursor that improves the performance of cells in serum-free media and is required for the growth of some cell types. Insulin has cell-signaling functions and promotes the uptake of glucose and amino acids. Transferrin is a nontoxic carrier of iron and reduces the generation of toxic free-radicals and peroxide. Selenium is required for the activity of glutathione peroxidase, thioredoxin reductase, and other antioxidant enzymes.

The new ITSE supplement is provided as a sterile 100x liquid formula that users should find easy to use and cost-effective compared to other insulin or transferrin supplements, or serum.

"There are no other insulin-transferrin supplements on the market today that provide the confidence of using our completely animal-free, recombinant sources of insulin and transferrin", said Mary Ann Santos, product scientist at InVitria.

Related Links:

InVitria



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
HPV Test
Allplex HPV28 Detection

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
21 Jun 2010  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
21 Jun 2010  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
21 Jun 2010  |   BioResearch